The DxC 500i enables seamless consolidation of chemistry and immunoassay testing, reducing manual interventions while optimizing turnaround times. The system is engineered to support mid-sized laboratories by delivering reliable, high-quality results with an intuitive interface and scalable capabilities.

"Innovations like the DxC 500i Clinical Analyzer enable Beckman Coulter to address the needs of networked laboratories with specific solutions for satellite or independent laboratories, as well as core laboratories," said Kathleen Orland, Chief Portfolio Officer for Beckman Coulter Diagnostics. "Beyond ensuring appropriate throughput levels for a networked lab, Beckman Coulter's common reagents and consumables across its scalable clinical chemistry and immunoassay portfolio enables common reference ranges, offering IDNs strategic benefits in patient care and inventory management."

With this latest advancement, Beckman Coulter continues to redefine laboratory diagnostics, empowering healthcare providers with cutting-edge technology that enhances productivity and improves patient outcomes.